UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly

Ferreira, Isabella ATM; Lee, Colin YC; Foster, William S; Abdullahi, Adam; Dratva, Lisa M; Tuong, Zewen Kelvin; Stewart, Benjamin J; ... Gupta, Ravindra K; + view all (2023) Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly. Cell Reports , 42 (8) , Article 112991. 10.1016/j.celrep.2023.112991. Green open access

[thumbnail of McCoy_Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly_VoR.pdf]
Preview
PDF
McCoy_Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly_VoR.pdf - Published Version

Download (6MB) | Preview

Abstract

Suboptimal responses to a primary vaccination course have been reported in the elderly, but there is little information regarding the impact of age on responses to booster third doses. Here, we show that individuals 70 years or older (median age 73, range 70-75) who received a primary two-dose schedule with AZD1222 and booster third dose with mRNA vaccine achieve significantly lower neutralizing antibody responses against SARS-CoV-2 spike pseudotyped virus compared with those younger than 70 (median age 66, range 54-69) at 1 month post booster. Impaired neutralization potency and breadth post third dose in the elderly is associated with circulating "atypical" spike-specific B cells expressing CD11c and FCRL5. However, when considering individuals who received three doses of mRNA vaccine, we did not observe differences in neutralization or enrichment in atypical B cells. This work highlights the finding that AdV and mRNA COVID-19 vaccine formats differentially instruct the memory B cell response.

Type: Article
Title: Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.celrep.2023.112991
Publisher version: https://doi.org/10.1016/j.celrep.2023.112991
Language: English
Additional information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: AZD1222, BNT162b2, CP: Immunology, SARS-CoV-2, elderly
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10175577
Downloads since deposit
546Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item